MENLO PARK, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. is scheduled to present at the 24th Annual JPMorgan Healthcare Conference on Thursday, January 12, 2006, at the Westin St. Francis Hotel in San Francisco. Frank Litvack, M.D., Chairman and CEO, will provide a corporate update at 10:00 AM Pacific Time.
To access the live audio broadcast or the subsequent archived recording, visit the webcast section of the company's website located at www.conormed.com. The recording will be archived for 30 days following the live presentation. Please log on to Conor's website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary.
About Conor Medsystems
Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug- eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit www.conormed.com.
Conor Medsystems, Inc.CONTACT: Investor inquiries: Michael Boennighausen, Chief FinancialOfficer of Conor Medsystems, Inc., +1-650-614-4100; or Media inquiries:Karen L. Bergman of BCC Partners, +1-650-575-1509, for Conor Medsystems,Inc.
Web site: http://www.conormed.com/
